Peripheral arterial disease (PAD) is associated with significant morbidity and mortality and is an important marker of systemic atherosclerosis. However, little is known about the associated risk factors for PAD in patients on maintenance hemodialysis (HD). We collected the basic data and possible risk factors associated with PAD for 277 patients on maintenance HD. Furthermore, we measured ankle-brachial blood pressure index (ABI) in these patients. PAD was defined as an ABI value less than 0.90. The prevalence of PAD in our HD center was 22.8% (61/268). Advanced age (P = 0.006), longer history of HD (P < 0.001), diabetes (P = 0.002) and presence of PAD symptoms (P < 0.001) were independent predictors of PAD. PAD patients with diabetes had shorter history of HD (P = 0.001). 2-vessel PAD had higher serum cholesterol in HD patients (≥ 200 vs < 200 mg/dL; Odds ratio, 12.12, 95% confidence interval, 2.199-67.79; P < 0.004).
Hirsh AT, Criqui MH, Treat-Jacobson D., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317-1324.
2.
O’Hare AM, Bacchetti P., Segal M., et al. Factors associated with future amputation among patients undergoing hemodialysis: results from the Dialysis Morbidity and Mortality Study Waves 3 and 4. Am J Kidney Dis. 2003;41(1):162-170.
3.
Smith FB, Lee AJ, Price JF, van Wijk MC, Fowkes FGChanges in ankle brachial index in symptomatic and asymptomatic subjects in the general population. J Vasc Surg. 2003;38(6):1323-1330.
4.
Ono K., Tsuchida A., Kawai H., et al. Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol. 2003;14(6):1591-1598.
5.
Collins TC, Petersen NJ, Suarez-Almazor M., Ashton CMThe prevalence of peripheral arterial disease in a racially diverse population . Arch Intern Med. 2003;163(12):1469-1474.
6.
Selvin E., Erlinger TPPrevalence of and risk factors for peripheral arterial disease in the United States. Circulation. 2004;110(6):738-743.
Kweon SS, Shin MH, Park KS, et al. Distribution of the ankle-brachial index and associated cardiovascular risk factors in a population of middle-aged and elderly Koreans. J Korean Med Sci. 2005;20(3):373-378.
10.
Tseng CHPrevalence and risk factors of peripheral arterial obstructive disease in Taiwanese type 2 diabetic patients. Angiology. 2000;54(3):331-338.
11.
United States Renal Data System.Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Division of Kidney, Urologic, and Hematologic Diseases ; 2000:339-348.
12.
Cheung AK, Sarnak MJ, Yan G., et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000;58(1):353-362.
13.
Murabito JM , Evans JC, Nieto K., Larson MG, Levy D., Wilson PWPrevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002;143(6):961-965.
14.
Drexel H., Steurer J., Muntwyler J., et al. Predictors of the presence and extent of peripheral arterial occlusive disease. Circulation. 1996;94(suppl 9):11199-11205.
15.
Schillinger M., Exner M., Mlekusch W., et al. Effect of smoking on restenosis during the 1st year after lower-limb endovascular interventions. Radiology. 2004;231(3):831-838.
16.
Ambalavanan N., Carlo WF, Bulger A., Shi J., Philips JBEffects of cigarette smoke extract on neonatal porcine vascular smooth muscle cells. Toxicol Appl Pharmacol . 2001;170(2):130-136.
17.
Goldberg IJWhy does diabetes increase atherosclerosis? I don’t know!. J Clin Invest. 2004;114(5):613-615.
18.
Iseki K., Yamazato M., Tozawa M., Takishita S.Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int. 2002;61(5): 1887-1893.
19.
Youssef F., Gupta P., Seifalian AM, Myint F., Mikhailidis DP, Hamilton G.The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease. Angiology. 2004;55(1): 53-62.
20.
Alnaeb ME, Youssef F., Mikhailidis DP, Hamilton G.Short-term lipid-lowering treatment with atorvastatin improves renal function but not renal blood flow indices in patients with peripheral arterial disease . Angiology. 2006;57(1):65-71.
21.
Curb JD, Masaki K., Rodriguez BL, et al. Peripheral artery disease and cardiovascular risk factors in the elderly. The Honolulu Heart Program. Arterioscler Thromb Vasc Biol. 1996;16(12):1495-1500.
